Literature DB >> 20736055

Antihypertensive and neuroprotective activities of rhynchophylline: the role of rhynchophylline in neurotransmission and ion channel activity.

Jiyin Zhou1, Shiwen Zhou.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Uncaria species (Gouteng in Chinese) have been used as ethnopharmacological medicines to treat ailments of the cardiovascular and central nervous systems. As the main alkaloid constituent of Uncaria species, rhynchophylline has drawn extensive attention in recent years for its antihypertensive and neuroprotective activities, and its pharmacological effects are related to ethnopharmacological medicine properties of Uncaria species. AIM OF THE REVIEW: This review examined the pharmacological studies and mechanisms of rhynchophylline, with an emphasis on cardiovascular and central nervous system diseases linked to the ethnopharmacological uses of Uncaria species.
METHODS: We conducted both an electronic search and a library search of in vivo and in vitro studies. The terms and keywords for the search included rhynchophylline, Uncaria species, Gouteng, pharmacological effects, and mechanism. We focused on the papers, including ours, with studies on all related pharmacological effects and mechanisms of rhynchophylline.
RESULTS: Rhynchophylline was the main constituent of several components identified from Uncaria species. Rhynchophylline mainly acts on cardiovascular and central nervous system diseases, including hypertension, bradycardia, arrhythmia, sedation, vascular dementia, epileptic seizures, drug addiction, and cerebral ischemia. Rhynchophylline also has effects on anticoagulation, inhibits vascular smooth muscle cell proliferation, and has been shown to be anti-endotoxemic. The active mechanisms are related to modulation of calcium and potassium ion channels, protection of neural and neuroglial cells, and regulation of central neurotransmitter transport and metabolism. More studies are necessary to verify the pharmacological activities and determine the exact mechanisms of rhynchophylline activity.
CONCLUSIONS: Rhynchophylline treatment of cardiovascular and central nervous system diseases has a strong linkage with traditional concepts and uses of Uncaria species in ethnopharmacological medicine, such as treatment for lightheadedness, convulsions, numbness, and hypertension. As a candidate drug for several cardiovascular and central nervous system diseases, rhynchophylline will attract scientists to pursue the potential pharmacological effects and mechanisms with new technologies. Relatively few clinically relevant studies of rhynchophylline have been conducted. Thus, more in vivo validations and investigations of antihypertensive and neuroprotective mechanisms of rhynchophylline are necessary.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20736055     DOI: 10.1016/j.jep.2010.08.041

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  31 in total

Review 1.  The role of phytochemicals in the treatment and prevention of dementia.

Authors:  Melanie-Jayne R Howes; Elaine Perry
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

2.  Rhynchophylline-induced vasodilation in human mesenteric artery is mainly due to blockage of L-type calcium channels in vascular smooth muscle cells.

Authors:  Peng-Yun Li; Xiao-Rong Zeng; Jun Cheng; Jing Wen; Isao Inoue; Yan Yang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-30       Impact factor: 3.000

Review 3.  Plant-based medicines for anxiety disorders, Part 1: a review of preclinical studies.

Authors:  Jerome Sarris; Erica McIntyre; David A Camfield
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

4.  Role of EphA4 signaling in the pathogenesis of amyotrophic lateral sclerosis and therapeutic potential of traditional Chinese medicine rhynchophylline.

Authors:  Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2015-07-05       Impact factor: 4.530

5.  Blockade of EphA4 signaling ameliorates hippocampal synaptic dysfunctions in mouse models of Alzheimer's disease.

Authors:  Amy K Y Fu; Kwok-Wang Hung; Huiqian Huang; Shuo Gu; Yang Shen; Elaine Y L Cheng; Fanny C F Ip; Xuhui Huang; Wing-Yu Fu; Nancy Y Ip
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

6.  Rhynchophylline Attenuates Tourette Syndrome via BDNF/NF-κB Pathway In Vivo and In Vitro.

Authors:  Hongyan Long; Jie Ruan; Mengjiao Zhang; Chunyan Wang; Yaruo Huang
Journal:  Neurotox Res       Date:  2019-06-26       Impact factor: 3.911

7.  Neuroprotective Effects of Rhynchophylline Against Aβ1-42-Induced Oxidative Stress, Neurodegeneration, and Memory Impairment Via Nrf2-ARE Activation.

Authors:  Pan Jiang; Lei Chen; Jian Xu; Wenyuan Liu; Feng Feng; Wei Qu
Journal:  Neurochem Res       Date:  2021-06-25       Impact factor: 3.996

8.  Endothelium-independent vasodilator effect of isocorynoxeine in vitro isolated from the hook of Uncaria rhynchophylla (Miquel).

Authors:  Ting Li; Ke Xu; Delu Che; Zhuangzhuang Huang; Nabila Jahan; Sicen Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-08-02       Impact factor: 3.000

9.  Permeability of rhynchophylline across human intestinal cell in vitro.

Authors:  Bo Ma; Jing Wang; Jing Sun; Ming Li; Huibo Xu; Guibo Sun; Xiaobo Sun
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

10.  Rhynchophylline Protects Against the Amyloid β-Induced Increase of Spontaneous Discharges in the Hippocampal CA1 Region of Rats.

Authors:  Hui Shao; Ze Mi; Wei-gang Ji; Cheng-huan Zhang; Teng Zhang; Shuan-cheng Ren; Zhi-ru Zhu
Journal:  Neurochem Res       Date:  2015-10-06       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.